Author/Authors :
Sun، نويسنده , , Tong-Wen and Xu، نويسنده , , Qing-Yan and Yao، نويسنده , , Hai-Mu and Zhang، نويسنده , , Xiao-Juan and Wu، نويسنده , , Qiong and Zhang، نويسنده , , Jin-Ying and Li، نويسنده , , Ling and Zhang، نويسنده , , Yan-Zhou and Kan، نويسنده , , Quan-Cheng and Guan، نويسنده , , Fang-Xia and Wang، نويسنده , , Le-Xin، نويسنده ,
Abstract :
Background
tudy was designed to evaluate the value of plasma cystatin C in predicting adverse cardiac events after percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS).
s
l of 605 patients (404 male, mean age 60.4 ± 10.6 years) with
Keywords :
Acute coronary syndrome , major adverse cardiac events , cystatin C , percutaneous coronary intervention , Prognosis
